E-drug: MSF briefing in 56th WHA (cont'd)
-------------------------------------------------------------------------
Dear Betty,
Up to now our first line for HAART is the combination AZT/3TC and
NVP or efavirenz. You can find the draft paper of the Best Practice
document that was distributed yesterday during the briefing in the
MSF-Access Campaign website (www.accessmed-msf.org). There
you will find more details about the programme. WHO intends to make
the final document available soon after WHA. Call me if you need
further information.
Regards,
Marta Darder
MSF South Africa
Ph +27 21 3645490
martad@xsinet.co.za
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug